Skip to Content

MYLAN 531 (Sulindac 200 mg)

Pill with imprint MYLAN 531 is Yellow, Round and has been identified as Sulindac 200 mg. It is supplied by Mylan Pharmaceuticals Inc..

Sulindac is used in the treatment of ankylosing spondylitis; familial adenomatous polyposis; gout, acute; bursitis; juvenile rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Sulindac 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 531

Sulindac

Imprint
MYLAN 531
Strength
200 mg
Color
Yellow
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-0531 Mylan Pharmaceuticals Inc.
51079-0667 UDL Laboratories Inc.
54569-4032 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.